LEGGETT & PLATT INC (LEG) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:LEG • US5246601075

12.61 USD
-0.04 (-0.32%)
At close: Feb 10, 2026
12.61 USD
0 (0%)
After Hours: 2/10/2026, 8:19:07 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

LEG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 60 industry peers in the Household Durables industry. LEG has only an average score on both its financial health and profitability. LEG is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • LEG had positive earnings in the past year.
  • LEG had a positive operating cash flow in the past year.
  • In multiple years LEG reported negative net income over the last 5 years.
  • Each year in the past 5 years LEG had a positive operating cash flow.
LEG Yearly Net Income VS EBIT VS OCF VS FCFLEG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

  • LEG has a better Return On Assets (6.37%) than 63.33% of its industry peers.
  • LEG's Return On Equity of 23.09% is amongst the best of the industry. LEG outperforms 91.67% of its industry peers.
  • LEG has a Return On Invested Capital (7.58%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LEG is in line with the industry average of 9.32%.
Industry RankSector Rank
ROA 6.37%
ROE 23.09%
ROIC 7.58%
ROA(3y)-3.65%
ROA(5y)0.38%
ROE(3y)-21.86%
ROE(5y)-4.68%
ROIC(3y)8%
ROIC(5y)8.74%
LEG Yearly ROA, ROE, ROICLEG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of LEG (5.38%) is better than 61.67% of its industry peers.
  • LEG has a Operating Margin (6.28%) which is in line with its industry peers.
  • LEG's Operating Margin has declined in the last couple of years.
  • The Gross Margin of LEG (18.28%) is worse than 78.33% of its industry peers.
  • LEG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.28%
PM (TTM) 5.38%
GM 18.28%
OM growth 3Y-18.8%
OM growth 5Y-10.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.29%
GM growth 5Y-4.1%
LEG Yearly Profit, Operating, Gross MarginsLEG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LEG is destroying value.
  • The number of shares outstanding for LEG has been increased compared to 1 year ago.
  • The number of shares outstanding for LEG has been increased compared to 5 years ago.
  • Compared to 1 year ago, LEG has a worse debt to assets ratio.
LEG Yearly Shares OutstandingLEG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LEG Yearly Total Debt VS Total AssetsLEG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • LEG has an Altman-Z score of 3.04. This indicates that LEG is financially healthy and has little risk of bankruptcy at the moment.
  • LEG has a Altman-Z score (3.04) which is in line with its industry peers.
  • The Debt to FCF ratio of LEG is 5.35, which is a neutral value as it means it would take LEG, 5.35 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of LEG (5.35) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.54 is on the high side and indicates that LEG has dependencies on debt financing.
  • LEG has a worse Debt to Equity ratio (1.54) than 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF 5.35
Altman-Z 3.04
ROIC/WACC0.89
WACC8.54%
LEG Yearly LT Debt VS Equity VS FCFLEG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • LEG has a Current Ratio of 2.15. This indicates that LEG is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of LEG (2.15) is worse than 60.00% of its industry peers.
  • A Quick Ratio of 1.35 indicates that LEG should not have too much problems paying its short term obligations.
  • LEG has a better Quick ratio (1.35) than 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.35
LEG Yearly Current Assets VS Current LiabilitesLEG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • LEG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.45%.
  • The earnings per share for LEG have been decreasing by -16.39% on average. This is quite bad
  • The Revenue has decreased by -6.06% in the past year.
  • Measured over the past years, LEG shows a decrease in Revenue. The Revenue has been decreasing by -1.60% on average per year.
EPS 1Y (TTM)-5.45%
EPS 3Y-27.71%
EPS 5Y-16.39%
EPS Q2Q%-9.38%
Revenue 1Y (TTM)-6.06%
Revenue growth 3Y-4.75%
Revenue growth 5Y-1.6%
Sales Q2Q%-5.93%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.17% on average over the next years.
  • Based on estimates for the next years, LEG will show a decrease in Revenue. The Revenue will decrease by -0.23% on average per year.
EPS Next Y0.76%
EPS Next 2Y2.28%
EPS Next 3Y5.09%
EPS Next 5Y7.17%
Revenue Next Year-6.87%
Revenue Next 2Y-5.35%
Revenue Next 3Y-2.22%
Revenue Next 5Y-0.23%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LEG Yearly Revenue VS EstimatesLEG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
LEG Yearly EPS VS EstimatesLEG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.12 indicates a correct valuation of LEG.
  • LEG's Price/Earnings ratio is a bit cheaper when compared to the industry. LEG is cheaper than 65.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.03. LEG is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 11.48, which indicates a very decent valuation of LEG.
  • Based on the Price/Forward Earnings ratio, LEG is valued cheaper than 81.67% of the companies in the same industry.
  • LEG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.97.
Industry RankSector Rank
PE 12.12
Fwd PE 11.48
LEG Price Earnings VS Forward Price EarningsLEG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 71.67% of the companies in the same industry are more expensive than LEG, based on the Enterprise Value to EBITDA ratio.
  • LEG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LEG is cheaper than 88.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.11
EV/EBITDA 7.11
LEG Per share dataLEG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)15.96
PEG (5Y)N/A
EPS Next 2Y2.28%
EPS Next 3Y5.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • LEG has a Yearly Dividend Yield of 1.58%.
  • LEG's Dividend Yield is a higher than the industry average which is at 1.17.
  • LEG's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.58%

5.2 History

  • The dividend of LEG decreases each year by -8.18%.
  • LEG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-8.18%
Div Incr Years0
Div Non Decr Years0
LEG Yearly Dividends per shareLEG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 11.94% of the earnings are spent on dividend by LEG. This is a low number and sustainable payout ratio.
DP11.94%
EPS Next 2Y2.28%
EPS Next 3Y5.09%
LEG Yearly Income VS Free CF VS DividendLEG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M
LEG Dividend Payout.LEG Dividend Payout, showing the Payout Ratio.LEG Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

LEGGETT & PLATT INC

NYSE:LEG (2/10/2026, 8:19:07 PM)

After market: 12.61 0 (0%)

12.61

-0.04 (-0.32%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-27
Earnings (Next)02-11
Inst Owners85.29%
Inst Owner Change0.55%
Ins Owners0.88%
Ins Owner Change-7.9%
Market Cap1.71B
Revenue(TTM)4.17B
Net Income(TTM)224.40M
Analysts48
Price Target12.75 (1.11%)
Short Float %4.15%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield 1.58%
Yearly Dividend1.02
Dividend Growth(5Y)-8.18%
DP11.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.8%
Min EPS beat(2)-2.61%
Max EPS beat(2)-0.99%
EPS beat(4)2
Avg EPS beat(4)2.08%
Min EPS beat(4)-2.61%
Max EPS beat(4)9.25%
EPS beat(8)2
Avg EPS beat(8)-1.02%
EPS beat(12)3
Avg EPS beat(12)0.68%
EPS beat(16)6
Avg EPS beat(16)2.04%
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)0.04%
Revenue beat(4)2
Avg Revenue beat(4)-0.02%
Min Revenue beat(4)-1.12%
Max Revenue beat(4)1.77%
Revenue beat(8)2
Avg Revenue beat(8)-0.76%
Revenue beat(12)3
Avg Revenue beat(12)-1.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)0%
PT rev (3m)29.31%
EPS NQ rev (1m)-1.06%
EPS NQ rev (3m)-1.06%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-0.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.12
Fwd PE 11.48
P/S 0.41
P/FCF 6.11
P/OCF 5.04
P/B 1.76
P/tB 13.3
EV/EBITDA 7.11
EPS(TTM)1.04
EY8.25%
EPS(NY)1.1
Fwd EY8.71%
FCF(TTM)2.06
FCFY16.37%
OCF(TTM)2.5
OCFY19.85%
SpS30.81
BVpS7.18
TBVpS0.95
PEG (NY)15.96
PEG (5Y)N/A
Graham Number12.96
Profitability
Industry RankSector Rank
ROA 6.37%
ROE 23.09%
ROCE 9.59%
ROIC 7.58%
ROICexc 9.11%
ROICexgc 14.5%
OM 6.28%
PM (TTM) 5.38%
GM 18.28%
FCFM 6.7%
ROA(3y)-3.65%
ROA(5y)0.38%
ROE(3y)-21.86%
ROE(5y)-4.68%
ROIC(3y)8%
ROIC(5y)8.74%
ROICexc(3y)8.89%
ROICexc(5y)9.67%
ROICexgc(3y)18.06%
ROICexgc(5y)21.73%
ROCE(3y)10.16%
ROCE(5y)11.09%
ROICexgc growth 3Y-24.14%
ROICexgc growth 5Y-12.98%
ROICexc growth 3Y-12.28%
ROICexc growth 5Y-5.12%
OM growth 3Y-18.8%
OM growth 5Y-10.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.29%
GM growth 5Y-4.1%
F-Score8
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF 5.35
Debt/EBITDA 3.87
Cap/Depr 47.6%
Cap/Sales 1.42%
Interest Coverage 250
Cash Conversion 87.66%
Profit Quality 124.6%
Current Ratio 2.15
Quick Ratio 1.35
Altman-Z 3.04
F-Score8
WACC8.54%
ROIC/WACC0.89
Cap/Depr(3y)59.68%
Cap/Depr(5y)54.18%
Cap/Sales(3y)2.07%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.45%
EPS 3Y-27.71%
EPS 5Y-16.39%
EPS Q2Q%-9.38%
EPS Next Y0.76%
EPS Next 2Y2.28%
EPS Next 3Y5.09%
EPS Next 5Y7.17%
Revenue 1Y (TTM)-6.06%
Revenue growth 3Y-4.75%
Revenue growth 5Y-1.6%
Sales Q2Q%-5.93%
Revenue Next Year-6.87%
Revenue Next 2Y-5.35%
Revenue Next 3Y-2.22%
Revenue Next 5Y-0.23%
EBIT growth 1Y-1.06%
EBIT growth 3Y-22.65%
EBIT growth 5Y-12.17%
EBIT Next Year47.69%
EBIT Next 3Y16.11%
EBIT Next 5Y11.08%
FCF growth 1Y-40.89%
FCF growth 3Y10.81%
FCF growth 5Y-15.65%
OCF growth 1Y-43.33%
OCF growth 3Y4.06%
OCF growth 5Y-14.47%

LEGGETT & PLATT INC / LEG FAQ

What is the fundamental rating for LEG stock?

ChartMill assigns a fundamental rating of 4 / 10 to LEG.


What is the valuation status of LEGGETT & PLATT INC (LEG) stock?

ChartMill assigns a valuation rating of 6 / 10 to LEGGETT & PLATT INC (LEG). This can be considered as Fairly Valued.


Can you provide the profitability details for LEGGETT & PLATT INC?

LEGGETT & PLATT INC (LEG) has a profitability rating of 4 / 10.


What is the valuation of LEGGETT & PLATT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LEGGETT & PLATT INC (LEG) is 12.12 and the Price/Book (PB) ratio is 1.76.


What is the earnings growth outlook for LEGGETT & PLATT INC?

The Earnings per Share (EPS) of LEGGETT & PLATT INC (LEG) is expected to grow by 0.76% in the next year.